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A considerable proportion of the general public experi-
ences negative health effects triggered by certain aller-
gens contained in their habitual diet. Usually the
recommended option is to eliminate from the diet the
food ingredients to which hypersensitivity has been
found. Allergic persons need to know whether the food
items they purchase contain them and they have to rely
on the truthfulness of information given on the label of
packaged food items. Legislation has been put in place
which requires food business operators to declare
whether ingredients with a known allergenic potential
have been used during manufacturing. Analytical testing
systems are needed by the food industry to enable them
to test whether allergens are present in their raw materi-
als, the finished products and whether production lines
have been correctly sanitised, by the food inspection
authorities for market surveillance and by academia to
enable and stimulate research into food allergy and
allergen detection. Immunochemistry based tests, and in
particular ELISAs, are definitely the most widely applied
tool in routine as well as research laboratories for the
determination of food allergens. Lateral flow devices are,
in terms of simplicity of application and user friendli-
ness, probably the most advanced analytical tools for the
rapid detection of allergens. They are widely applied in
the food manufacturing industries for the control of
production lines. Food processing can have a profound
impact on the detectability of allergens by ELISA based
methods. Advantages but also the inherent disadvan-
tages of ELISA tests, and in particular the importance of
validating such methods properly by including naturally
incurred test materials in validation exercises, are
important aspects, which have to be addressed in an
appropriate manner by test developers, end-users and
validation/standardisation bodies. Comparability of
testing results produced by different assays is not always
ensured, and approaches how to achieve this (e.g. clearer
definition of what entity is measured, use of well charac-
terised materials for calibration, etc) should be explored
to improve the equivalence of testing results.
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